相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Ioannis Mykoniatis et al.
JOURNAL OF SEXUAL MEDICINE (2022)
Pharmacotherapy for Erectile Dysfunction in 2021 and Beyond
Farnoosh Nik-Ahd et al.
UROLOGIC CLINICS OF NORTH AMERICA (2022)
A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction
Mohammadsadegh Hamzehnejadi et al.
SEXUAL MEDICINE REVIEWS (2022)
European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction
Andrea Salonia et al.
EUROPEAN UROLOGY (2021)
Novel Emerging Therapies for Erectile Dysfunction
Soyeun Kim et al.
WORLD JOURNAL OF MENS HEALTH (2021)
Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis
Andreu Fernandez-Codina et al.
CLINICAL RHEUMATOLOGY (2020)
Pharmacology and perspectives in erectile dysfunction in man
Emma Mitidieri et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors?
Michael E. Rezaee et al.
JOURNAL OF SEXUAL MEDICINE (2020)
Emerging Treatments for Erectile Dysfunction: a Review of Novel, Non-surgical Options
Darshan P. Patel et al.
CURRENT UROLOGY REPORTS (2019)
The intra-meatal application of alprostadil cream (Vitaros®) improves drug efficacy and patient's satisfaction: results from a randomized, two-administration route, cross-over clinical trial
Tommaso Cai et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2019)
Stimulators and activators of soluble guanylate cyclase for urogenital disorders
Fabiola Z. Monica et al.
NATURE REVIEWS UROLOGY (2018)
Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study
David J. Ralph et al.
JOURNAL OF SEXUAL MEDICINE (2018)
Erectile Dysfunction: AUA Guideline
Arthur L. Burnett et al.
JOURNAL OF UROLOGY (2018)
Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil
I. Moncada et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2018)
Botulinum Neurotoxin and Its Potential Role in the Treatment of Erectile Dysfunction
Hussein Ghanem et al.
SEXUAL MEDICINE REVIEWS (2018)
Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction
Faysal A. Yafi et al.
SEXUAL MEDICINE REVIEWS (2018)
Transdermal delivery of tadalafil using a novel formulation
Jong-Suep Baek et al.
DRUG DELIVERY (2016)
Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
Konstantinos Hatzimouratidis et al.
JOURNAL OF SEXUAL MEDICINE (2016)
Avanafil - a further step to tailoring patient needs and expectations
Luca Boeri et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicentre Study (The ANDAST Trial)
Mario Malerba et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: A Trade-off Network Meta-analysis
Liang Chen et al.
EUROPEAN UROLOGY (2015)
Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients?
Antonio Aversa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Treatment Satisfaction of Men and Partners Following Switch from On-Demand Phosphodiesterase Type 5 Inhibitor Therapy to Tadalafil 5 mg Once Daily
Patrick R. Burns et al.
JOURNAL OF SEXUAL MEDICINE (2015)
Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study
Kellen L. Meadows et al.
SUPPORTIVE CARE IN CANCER (2015)
Clinical efficacy and safety of Vitaros©/Virirec© (Alprostadil cream) for the treatment of erectile dysfunction
Ignacio Moncada et al.
UROLOGIA JOURNAL (2015)
Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients
S-C Kim et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2014)
Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
JinQiu Yuan et al.
EUROPEAN UROLOGY (2013)
Efficacy and Safety of Once-Daily Tadalafil in Men with Erectile Dysfunction Who Reported No Successful Intercourse Attempts at Baseline
Ridwan Shabsigh et al.
JOURNAL OF SEXUAL MEDICINE (2013)
SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction
Hartmut Porst et al.
JOURNAL OF SEXUAL MEDICINE (2013)
A review of outcomes of an intracavernosal injection therapy programme
Peter G. Coombs et al.
BJU INTERNATIONAL (2012)
EAU Guidelines on Penile Curvature
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2012)
Dropout in the Treatment of Erectile Dysfunction with PDE5: A Study on Predictors and a Qualitative Analysis of Reasons for Discontinuation
Ana A. Carvalheira et al.
JOURNAL OF SEXUAL MEDICINE (2012)
The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
Ajay Nehra et al.
MAYO CLINIC PROCEEDINGS (2012)
The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study
Ahmet Gokce et al.
BJU INTERNATIONAL (2011)
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles
Yosra S. R. Elnaggar et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
Onset of Efficacy of Tadalafil Once Daily in Men With Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Trial
Allen Seftel et al.
JOURNAL OF UROLOGY (2011)
Drug Interactions With Phosphodiesterase-5 Inhibitors Used for the Treatment of Erectile Dysfunction or Pulmonary Hypertension
Bryan G. Schwartz et al.
CIRCULATION (2010)
Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2010)
Discovery of a Selective Small-Molecule Melanocortin-4 Receptor Agonist with Efficacy in a Pilot Study of Sexual Dysfunction in Humans
Mark I. Lansdell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study
M. J. Mathers et al.
ANDROLOGIA (2009)
Transdermal Delivery of Tadalafil. I. Effect of Vehicles on Skin Permeation
Gamal M. El Maghraby et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2009)
Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
R. Sadovsky et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Long-term, Multicenter Study of the Safety and Efficacy of Topical Alprostadil Cream in Male Patients with Erectile Dysfunction
Michael Rooney et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction
W. Wallace Dinsmore et al.
BJU INTERNATIONAL (2008)
Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline
R. Shabsigh et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2008)
The use of phosphodiesterase 5 inhibitors with concomitant medications
G. Corona et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance
Christina Ljunggren et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
Claus G. Roehrborn et al.
JOURNAL OF UROLOGY (2008)
Cyclic nucleotide signaling mechanisms in trypanosomes: Possible targets for therapeutic agents
Sunil Laxman et al.
MOLECULAR INTERVENTIONS (2007)
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy:: post hoc analysis of data from a multicentre, randomized, open-label, crossover study
Ian Eardley et al.
BJU INTERNATIONAL (2007)
hMaxi-K gene transfer in males with erectile dysfunction:: Results of the first human trial
Arnold Melman et al.
HUMAN GENE THERAPY (2006)
Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections
K. Nandipati et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients
Harin Padma-Nathan et al.
UROLOGY (2006)
Treatment strategy for non-responders to tadalafil and vardenafil: A real-life study
Konstantinos Hatzimouratidis et al.
EUROPEAN UROLOGY (2006)
Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction
AI El-Sakka
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2006)
Predictors and prevalence of erectile dysfunction in a racially diverse population
CS Saigal et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Combination therapy: Medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy
R Raina et al.
JOURNAL OF ANDROLOGY (2005)
Testosterone and sleep-related erections: An overview
F Montorsi et al.
JOURNAL OF SEXUAL MEDICINE (2005)
A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1
R Seyam et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2005)
Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
YH Jeon et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®
RC Rosen et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
LE Diamond et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy
CG McMahon
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2003)
AC-NLE-c[Asp-His-DPhe-Arg-Trp-Lys]-NH2 induces penile erection via brain and spinal melanocortin receptors
H Wessells et al.
NEUROSCIENCE (2003)
Topical alprostadil cream for the treatment of erectile dysfunction: A combined analysis of the phase II program
C Steidle et al.
UROLOGY (2002)
Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
GB Brock et al.
JOURNAL OF UROLOGY (2002)
A role for the melanocortin 4 receptor in sexual function
LHT Van der Ploeg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy
A Nehra et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2002)
Potassium channels and erectile dysfunction
SL Archer
VASCULAR PHARMACOLOGY (2002)
Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'
M Braun et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2000)
Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II
H Wessells et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2000)
Erectile dysfunction: from biochemical pharmacology to advances in medical therapy
M Maggi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy
JH Mydlo et al.
EUROPEAN UROLOGY (2000)
Optimizing the therapeutic approach of transurethral alprostadil
P Ekman et al.
BJU INTERNATIONAL (2000)
Drug therapy: Erectile dysfunction.
TF Lue
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
